e-learning
resources
Virtual 2021
07.09.2021
What's new in respiratory problems in rare and systemic diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Can we treat Exercise Induced Laryngeal Obstruction with inhaled ipratropiumbromide?
P. Muralitharan (Bergen, Norway), P. Carlsen (Bergen, Norway), M. Vollsæter (Bergen, Norway), M. Engan (Bergen, Norway), I. Jansrud Hammer (Bergen, Norway), T. Halvorsen (Bergen, Norway), O. Drange Røksund (Bergen, Norway), H. Havstad Clemm (Bergen, Norway)
Source:
Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Session:
What's new in respiratory problems in rare and systemic diseases
Session type:
E-poster
Number:
3307
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Muralitharan (Bergen, Norway), P. Carlsen (Bergen, Norway), M. Vollsæter (Bergen, Norway), M. Engan (Bergen, Norway), I. Jansrud Hammer (Bergen, Norway), T. Halvorsen (Bergen, Norway), O. Drange Røksund (Bergen, Norway), H. Havstad Clemm (Bergen, Norway). Can we treat Exercise Induced Laryngeal Obstruction with inhaled ipratropiumbromide?. 3307
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Definition and history of sarcoidosis
Evidence of early abnormal airways’ inflammation in children with type 1 diabetes
Related content which might interest you:
Bronchial Rheoplasty Increases Distal Airway Volume in Chronic Bronchitis
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019
Nasal High-flow Versus Non-invasive Ventilation In Patients With Chronic Hypercapnic COPD
Source: Virtual Congress 2020 – ALERT: Ventilation and rehabilitation
Year: 2020
The Effect of Bronchial Thermoplasty on Lung Function in Severe Asthma Patients
Source: International Congress 2018 – New perspectives on asthma, cough and laryngeal obstruction
Year: 2018
Prognostic Factor of Airflow Obstruction and bronchodilator therapy in Patients with Bronchiectasis
Source: International Congress 2019 – Clinical problems
Year: 2019
Investigating Exercise Induced Laryngeal Obstruction (EILO): A review of a specialist paediatric service
Source: International Congress 2018 – Evolving approaches to differential diagnosis
Year: 2018
Nebulized Ipratropium Bromide Protects against Tracheal and Bronchial Secretion during Bronchoscopy:A Randomized Controlled Trial
Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease
Year: 2019
Weight-adjusted Intravenous Reslizumab Attenuates Airway Eosinophilia in Severe Asthmatics compared to 100 mg Subcutaneous Mepolizumab
Source: International Congress 2017 – Monitoring asthma control
Year: 2017
Nebulizer Location and spontaneous breathing on Aerosol Delivery during Airway Pressure Release Ventilation in Adult Lung Model
Source: International Congress 2018 – Preclinical and clinical studies of critical illness
Year: 2018
Effects of inhaled salmeterol/fluticasone on lung function in patients with bronchiectasis
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014
Dysphonia in asthmatic women using inhaled corticosteroids: It is not only a laryngeal inflammation
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Long-acting anticholinergics in the treatment of severe asthma with irreversible airway obstruction
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis (APAP)
Source: Virtual Congress 2020 – ALERT: Pneumothorax, cough, PAH, alveolar proteinosis
Year: 2020
Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017
Interaction between RPL554 and glycopyrronium bromide in small human airways
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014
LATE-BREAKING ABSTRACT: Blood Eosinophil Count as a Biomarker of ICS Effectiveness in Reducing Exacerbation Rates in COPD
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014
Relationship between Neutrophilic Airway Inflammation and Airway Colonisation in non-Cystic Fibrosis Bronchiectasis
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018
LATE-BREAKING ABSTRACT: Is Blood Eosinophil Count a Predictor of Response to Bronchodilators in COPD?
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014
Characterize Idiopathic Pulmonary Fibrosis using Respiratory Oscillometry
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020
Ozone and Sensitization Alter Airway and Nerve-associated Eosinophils
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017
Metered Cryospray Modulates Bronchial Epithelial Gene Expression in Patients with Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Interventional pulmonology: unity in diversity
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept